Records containing: Multiple Sclerosis, Relapsing-remitting
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-09-01Peer Support Impact on Therapeutic Adherence in Patients With Multiple Sclerosis: a Mixed Methods Randomized Controlled Trial Pilot Study
-
CLINICAL_TRIALS study record update · 2022-05-09Post Marketing Surveillance Study for Tecfidera (Dimethyl Fumarate) Capsules in Korean Patients With Relapsing-Remitting Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2019-08-12Randomized Control Trial Evaluation of a Modified Paleolithic Dietary Intervention in the Treatment of Relapsing-Remitting Multiple Sclerosis: A Pilot Study
-
CLINICAL_TRIALS study record update · 2016-04-25A Prospective, Observational, International, Multi-center Study to Measure the Relationship Between Relapse and Adherence in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients Treated With Rebismart®2.0 + MSdialog™, Assessing Quality of Life (ADHERQOL)
-
CLINICAL_TRIALS study record update · 2016-02-12Assessment of Lesion Activity Analysis in the Avonex- Steroid Azathioprine (ASA) Study
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-02-01Pharmacodynamic and Immunologic Effects of Vitamin D Supplementation in Patients With Multiple Sclerosis and Healthy Controls
-
CLINICAL_TRIALS study record update · 2014-03-07Impact of Fatigue in the Quality of Life of Patients With Multiple Sclerosis in Argentina
-
CLINICAL_TRIALS study record update · 2013-11-04Neuropsychological Assessments in the Multiple Sclerosis Clinic
-
CLINICAL_TRIALS study record update · 2013-08-06A Randomized, Multicenter, Parallel Group, Open-label Study Comparing the Tolerability of Rebif® Injection With and Without the Use of Rebiject™Mini in Relapsing Remitting MS Patients